{
  "node": {
    "slug": "breast-cancer",
    "network": "breast_cancer_trials",
    "title": "Breast cancer trials",
    "description": "Recruiting breast cancer studies from ClinicalTrials.gov, with eligibility criteria structured for private pre-screening."
  },
  "disclaimer": "Demo node, not a real trial site; pre-screening only, not medical advice.",
  "source": {
    "name": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/",
    "retrieved": "2026-11-16",
    "modified": "Fields selected and summaries shortened by ChartStays; eligibility criteria structured and coded. Each study links to its authoritative ClinicalTrials.gov record."
  },
  "studies": [
    {
      "nct_id": "NCT07776613",
      "title": "A Study of Romosozumab in People With Breast Cancer and Osteoporosis",
      "status": "RECRUITING",
      "conditions": [
        "Breast Cancer",
        "Metastatic Breast Cancer (MBC)"
      ],
      "phases": [
        "PHASE2"
      ],
      "sponsor": "Memorial Sloan Kettering Cancer Center",
      "summary": "The researchers are doing this study to see if romosozumab is effective at helping with bone formation in people with metastatic breast cancer (MBC) that has spread to the bones. All participants will have osteoporosis. The researchers will also look at bone breakdown (resorption) in participants and determine if romosozumab is a safe treatment for osteoporosis in people with MBC that has spread…",
      "url": "https://clinicaltrials.gov/study/NCT07776613",
      "last_update_posted": "2026-08-20",
      "criteria": "./criteria/NCT07776613.json",
      "logistics": "./logistics/NCT07776613.json",
      "structured_criteria": 4,
      "free_text_criteria": 9
    },
    {
      "nct_id": "NCT05440227",
      "title": "PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients",
      "status": "RECRUITING",
      "conditions": [
        "Cancer-related Fatigue"
      ],
      "phases": [
        "PHASE2"
      ],
      "sponsor": "PhytoHealth Corporation",
      "summary": "The objective of this study is to assess the efficacy of weekly PG2 regimen as a complementary treatment for patients with recurrent unresectable (local or regional) or metastatic breast cancer who experienced moderate to severe fatigue while receiving chemotherapies.",
      "url": "https://clinicaltrials.gov/study/NCT05440227",
      "last_update_posted": "2025-06-05",
      "criteria": "./criteria/NCT05440227.json",
      "logistics": "./logistics/NCT05440227.json",
      "structured_criteria": 5,
      "free_text_criteria": 24
    },
    {
      "nct_id": "NCT06858449",
      "title": "Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer",
      "status": "RECRUITING",
      "conditions": [
        "Cancer",
        "Breast Cancer"
      ],
      "phases": [
        "NA"
      ],
      "sponsor": "Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)",
      "summary": "In this study, the investigators hypothesize that a high dose of post-workout protein nutrition regimen focused on food quality and an observed exercise regimen utilizing high-load resistance training initiated during or after cancer treatment will improve body composition and functional capacity.",
      "url": "https://clinicaltrials.gov/study/NCT06858449",
      "last_update_posted": "2026-02-03",
      "criteria": "./criteria/NCT06858449.json",
      "logistics": "./logistics/NCT06858449.json",
      "structured_criteria": 3,
      "free_text_criteria": 9
    },
    {
      "nct_id": "NCT06461650",
      "title": "Preoperative Nicotine Cessation for Women With Breast Cancer Recommended for Reconstruction",
      "status": "RECRUITING",
      "conditions": [
        "Breast Cancer"
      ],
      "phases": [
        "NA"
      ],
      "sponsor": "University of Florida",
      "summary": "Close to 20% of cancer patients currently use nicotine products. Nicotine use in breast cancer patients is associated with poorer overall outcomes, including worsened survival and increased surgical complications. Nicotine cessation is rarely addressed in breast cancer patients at the time of diagnosis and may be a missed opportunity to optimize patient outcomes. Patients that use nicotine produc…",
      "url": "https://clinicaltrials.gov/study/NCT06461650",
      "last_update_posted": "2026-06-25",
      "criteria": "./criteria/NCT06461650.json",
      "logistics": "./logistics/NCT06461650.json",
      "structured_criteria": 4,
      "free_text_criteria": 9
    },
    {
      "nct_id": "NCT07021846",
      "title": "Dose Escalated Concomitant Boost Radiotherapy for Early Breast Cancer",
      "status": "RECRUITING",
      "conditions": [
        "Breast Cancer"
      ],
      "phases": [
        "NA"
      ],
      "sponsor": "Fondazione Policlinico Universitario Campus Bio-Medico",
      "summary": "The goal of this prospective, single-arm, phase II, non-randomized trial is to evaluate an hypofractionation schedule with high dose simultaneous integrated tumor bed boost in early breast cancer patients. The main question\\[s\\] it aims to answer are: * evaluate the rate of all grades of radiation-induced fibrosis at 4 years. * evaluate poor/fair cosmesis rate Participants will be treated with hy…",
      "url": "https://clinicaltrials.gov/study/NCT07021846",
      "last_update_posted": "2025-06-15",
      "criteria": "./criteria/NCT07021846.json",
      "logistics": "./logistics/NCT07021846.json",
      "structured_criteria": 7,
      "free_text_criteria": 9
    }
  ]
}
